BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mposhi A, Liang L, Mennega KP, Yildiz D, Kampert C, Hof IH, Jellema PG, de Koning TJ, Faber KN, Ruiters MHJ, Niezen-Koning KE, Rots MG. The Mitochondrial Epigenome: An Unexplored Avenue to Explain Unexplained Myopathies? Int J Mol Sci 2022;23:2197. [PMID: 35216315 DOI: 10.3390/ijms23042197] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Ryva BA, Zhou Z, Goodrich JM, Strakovsky RS. The potential role of environmental factors in modulating mitochondrial DNA epigenetic marks. Vitam Horm 2023;122:107-45. [PMID: 36863791 DOI: 10.1016/bs.vh.2023.01.011] [Reference Citation Analysis]
2 Low HC, Chilian WM, Ratnam W, Karupaiah T, Md Noh MF, Mansor F, Ng ZX, Pung YF. Changes in Mitochondrial Epigenome in Type 2 Diabetes Mellitus. Br J Biomed Sci 2023;80:10884. [PMID: 36866104 DOI: 10.3389/bjbs.2023.10884] [Reference Citation Analysis]
3 Rautenberg EK, Hamzaoui Y, Coletta DK. Mini-review: Mitochondrial DNA methylation in type 2 diabetes and obesity. Front Endocrinol 2022;13:968268. [DOI: 10.3389/fendo.2022.968268] [Reference Citation Analysis]
4 Valenti D, Atlante A. Mitochondrial Bioenergetics in Different Pathophysiological Conditions 2.0. Int J Mol Sci 2022;23:5552. [PMID: 35628362 DOI: 10.3390/ijms23105552] [Reference Citation Analysis]